[go: up one dir, main page]

NO20081399L - New use of peptide compounds for the treatment of muscle pain - Google Patents

New use of peptide compounds for the treatment of muscle pain

Info

Publication number
NO20081399L
NO20081399L NO20081399A NO20081399A NO20081399L NO 20081399 L NO20081399 L NO 20081399L NO 20081399 A NO20081399 A NO 20081399A NO 20081399 A NO20081399 A NO 20081399A NO 20081399 L NO20081399 L NO 20081399L
Authority
NO
Norway
Prior art keywords
treatment
peptide compounds
new use
muscle pain
pain
Prior art date
Application number
NO20081399A
Other languages
Norwegian (no)
Inventor
Thomas Stohr
Bettina Beyreuther
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05017977A external-priority patent/EP1754476A1/en
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of NO20081399L publication Critical patent/NO20081399L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Foreliggende oppfinnelse er rettet mot anvendelse av en klasse av peptidforbindelser for behandling av ikke-inflammatorisk muskelskjelettsmerte og/eller ikke-inflammatorisk osteoartrittsmerte.The present invention is directed to the use of a class of peptide compounds for the treatment of non-inflammatory musculoskeletal pain and / or non-inflammatory osteoarthritis pain.

NO20081399A 2005-08-18 2008-03-17 New use of peptide compounds for the treatment of muscle pain NO20081399L (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05017977A EP1754476A1 (en) 2005-08-18 2005-08-18 Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
US81185906P 2006-06-08 2006-06-08
US81184006P 2006-06-08 2006-06-08
PCT/EP2006/008171 WO2007020103A2 (en) 2005-08-18 2006-08-18 Novel use of peptide compounds for treating muscle pain

Publications (1)

Publication Number Publication Date
NO20081399L true NO20081399L (en) 2008-05-09

Family

ID=37734042

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081399A NO20081399L (en) 2005-08-18 2008-03-17 New use of peptide compounds for the treatment of muscle pain

Country Status (3)

Country Link
KR (1) KR20080038408A (en)
IL (1) IL189077A0 (en)
NO (1) NO20081399L (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3114739B1 (en) * 2020-10-06 2022-08-26 Centre Nat Rech Scient NEW PEPTOIDS AND THEIR USE IN THE PREVENTION OR TREATMENT OF CHRONIC PAIN

Also Published As

Publication number Publication date
IL189077A0 (en) 2008-08-07
KR20080038408A (en) 2008-05-06

Similar Documents

Publication Publication Date Title
EA200800614A1 (en) NEW APPLICATIONS OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF MUSCLE PAIN
CY1110900T1 (en) CHEMICAL COMPOUNDS
CY1108275T1 (en) CHEMICAL COMPOUNDS
NO20070423L (en) New use of peptide compounds for the treatment of essential tremor and other tremor syndromes
EA200900959A1 (en) MEK INHIBITORS
EP1876990A4 (en) TREATMENT OF TEETH WITH ALIGNERS
CY1107956T1 (en) USE OF 2-AMINOTETRALINE SUBSTITUTES FOR PREVENTIVE TREATMENT OF PARKINS DISEASE
EA201190217A1 (en) SUBSTITUTED 2-ACETAMIDO-5-ARIL-1,2,4-TRIAZOLONES AND THEIR APPLICATION
BRPI0518829A2 (en) Method for the treatment of neuropathic pain and associated syndromes
NO20071585L (en) New use of peptide compounds for the treatment of bone pain, chemotherapy and nucleoside induced pain
EA200602221A1 (en) NEW APPLICATION OF PEPTIDE CONNECTIONS FOR THE TREATMENT OF PAIN IN TRIGEMINAL NEURALGIA
ATE445692T1 (en) POLYDEXTROSE INDUCED TWO PHASE COMPOSITION
ATE472998T1 (en) CATIONIC LIPOSOMAL PREPARATIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
EA200700702A1 (en) LOKSAPINA ANALOGUES AND METHODS OF THEIR APPLICATION
EP1965827A4 (en) TREATMENT OF DEMYELINISING DISEASES
EA200700400A1 (en) DERIVATIVES N- (1H-INDOLIL) -1H-INDOL-2-CARBOXAMIDES, THEIR PRODUCTION AND THEIR APPLICATION IN THERAPY
EA201400423A1 (en) PHARMACEUTICAL PREPARATIONS AND THEIR APPLICATION IN THE TREATMENT OF SEXUAL DYSFUNCTION IN WOMEN
NO20060535L (en) Aztreonam-L-lysine and methods for preparing it
SE0002739D0 (en) New use
EA200700102A1 (en) TREATMENT OF NEUROPATIC PAIN, FIBROMYALGIA OR RHEUMATOID ARTHRITIS
NO20081399L (en) New use of peptide compounds for the treatment of muscle pain
DK1579859T3 (en) Use of N- (2-arylpropionyl) sulfonamides to treat spinal cord injury
DK1513529T3 (en) THREE-TERM MONOAMIN RECOVERY INHIBITORS FOR TREATMENT OF CHRONIC PAIN
EA200501259A1 (en) COMBINED APPLICATION OF FIBRATE AND ORLISTAT FOR THE TREATMENT OF OBESITY
ATE482707T1 (en) 1-Ä2H-1-BENZOPYRAN-2-ON-8-YLÜ-PIPERAZINE DERIVATIVES FOR THE TREATMENT OF PAIN

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application